Wang (2020)
Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis
32267833
https://www.ncbi.nlm.nih.gov/pubmed/32267833
Comorbidities
Chronic liver disease (Present vs. Not present)
COVID-19 (severe/critical)
Odds ratio: 0.670 (0.300-1.490) Univariate analysis

China

Meta-analysis

Medical records

1558

A literature search was performed using the electronic platforms (PubMed, Cochrane Library, Embase, and other databases) to obtain relevant research studies published up to March 1, 2020.

A total of 1558 samples from 6 retrospective studies were enrolled in this meta-analysis. Studies: C.Huang, D.Wang, W.Guan, W.Liu, X.Xu, J.Zhang

0


COVID-19 (severe/critical)

324

The judgment criteria for severe and non-severe patients included in the study were not uniform


Comorbidities

Chronic liver disease

Liver disease is any disturbance of liver function that causes illness.

Not present

Present


Odds ratio

0.670 (0.300-1.490)

No

No

No

Hypertension, diabetes, COPD, cardiovascular disease, and cerebrovascular disease are major risk factors for patients with COVID-19. Knowledge of these risk factors can be a resource for clinicians in the early appropriate medical management of patients with COVID-19.


The meta-analysis revealed no correlation between increased risk of COVID-19 and liver disease, malignancy, or renal disease.

Good

Yes